2,3-Dimethoxyaniline → 1-(Tert-butoxycarbonyl)-4-(2,3-dimethoxyphenylamino)piperidine

HRID 395528

Reaktionsgleichung

Reaktionsgleichung von HRID 395528
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][C:11](=O)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[CH3:15][O:16][C:17]1[C:23]([O:24][CH3:25])=[CH:22][CH:21]=[CH:20][C:18]=1[NH2:19]>>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([NH:19][C:18]2[CH:20]=[CH:21][CH:22]=[C:23]([O:24][CH3:25])[C:17]=2[O:16][CH3:15])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]

Komponenten

3

Versuchsvorschrift

1-(tert-Butoxycarbonyl)-4-piperidone (4.78 g) and 2,3-dimethoxyaniline (3.68 g) were condensed in the same manner as described in Preparation Example 37 to give the title compound.

Aufarbeitung

  1. customcondensed in the same manner
  2. customas described in Preparation Example 37

Quellen und Nachweise

ORD-Eintrag
ord-2d60edcda598439db59e5a80ea3ebd75
Quelldatensatz
uspto-grants-2003_08
Patentnummer
US06605620B1

Verknüpfte Notizen

Wird geladen…